Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic barrett's esophagus

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 6, 2013, Pages 636-642

  Bulsiewicz, William J ^a   Kim, Hannah P ^a   Dellon, Evan S ^a   Cotton, Cary C ^a   Pasricha, Sarina ^a   Madanick, Ryan D ^a   Spacek, Melissa B ^a   Bream, Susan E ^a   Chen, Xiaoxin ^a   Orlando, Roy C ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ERADICATION THERAPY; ESOPHAGUS STENOSIS; FEMALE; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH CARCINOMA; OUTCOME ASSESSMENT; PERFORATION; POSTOPERATIVE HEMORRHAGE; RADIOFREQUENCY ABLATION; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84878116554     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.10.028     Document Type: Article

References (12)

1. Spechler S.J., Sharma P., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091. American Gastroenterological Association.
2. Sharma V.K., Jae Kim H., Das A., et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009, 104:310-317.
3. Bulsiewicz W.J., Shaheen N.J. The role of radiofrequency ablation in the management of Barrett's esophagus. Gastrointest Endosc Clin N Am 2011, 21:95-109.
4. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 2008, 68:35-40.
5. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-2288.
6. Shaheen N.J., Overholt B.F., Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011, 141:460-468.
7. Wani S., Sampliner R.E., Weston A.P., et al. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus. Aliment Pharmacol Ther 2005, 22:627-633.
8. Gerson L.B., Shetler K., Triadafilopoulos G. Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Dig Liver Dis 2005, 37:651-658.
9. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
10. Okoro N.I., Tomizawa Y., Dunagan K.T., et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012, 10:150-154.
11. Corley D.A., Kerlikowske K., Verma R., et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003, 124:47-56.
12. Korst R.J., Santana-Joseph S., Rutledge J.R., et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg 2011, 142:1168-1173.